NCT04509167View on ClinicalTrials.gov

Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 10, 2020

Primary Completion Date

June 24, 2022

Study Completion Date

June 24, 2022

Conditions
Neoplasms
Interventions
BIOLOGICAL

Neoantigen Peptides

Patients will receive intradermal injection of individualized neoantigen peptides vaccine at a dose of \~500ug per peptide once a week for 8 weeks.

Trial Locations (1)

22100

Instituto de Medicina Regenerativa, Tijuana

All Listed Sponsors
lead

Instituto de Medicina Regenerativa

INDUSTRY

NCT04509167 - Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms | Biotech Hunter | Biotech Hunter